F Fuzkk Atlas of Asia, the Middle East, Canada, Australia and Africa
#135Extended selection 101–300

Adimmune

Taiwan · East Asia

Vaccines and biological products

Manufacturing profile

Vaccines and biological products

Country: Taiwan

Macro-region: East Asia

Selection basis

The company is placed in positions 101–300 as a manufacturer, biotech, specialty-pharma, generics or CDMO company with practical relevance to the existing FUZKK catalog.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Representative manufacturing and QC chain

  1. 1Biological inputs and seed/cell-bank control
  2. 2Culture, antigen production or fractionation
  3. 3Purification and formulation
  4. 4Sterile filling or lyophilisation
  5. 5Potency, sterility, endotoxin and cold-chain evidence

Relevant FUZKK packages

Huvac — Human Vaccine QC UtilitiesPlasma-Derived Products QC SuiteLabEx QC Suite

Product/API utilities

Vaccine Potency AssessorAdjuvant Aluminum Assay CheckerAdjuvant Adsorption Efficiency Quality CheckerInactivated Vaccine Safety Test Quality CheckerLive Attenuated Vaccine Genetic Stability Quality CheckerPlasma Pool Traceability CheckerPlasma Viral Clearance Evidence CheckerCold Chain Shipping Temperature And MKT Quality Checker

Lumex — instrumental QC

System Suitability Parameters Checker

LabEx — laboratory QC

Bacterial Endotoxins LAL Quality CheckerSterility Test Membrane Filtration Quality Checker

Medical Devices — equipment and software lifecycle

Supplier Evaluation CheckerCalibration Status CheckerProcess Validation CheckerChange Control Impact CheckerRequirement Traceability CheckerData Integrity Security Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Methodology